Imunon, Inc. — Director's Dealing 2018

Apr 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2018-04-09

Reporting Person: Tardugno Michael H (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-09	Celsion Corporation Common Stock	P	2500	$2.30	Acquired	20200	Direct

Footnotes

F1: The shares were purchased on the open market.